|Bid||7.70 x 1000|
|Ask||7.71 x 3100|
|Day's range||7.65 - 8.03|
|52-week range||2.51 - 24.90|
|Beta (5Y monthly)||0.10|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Nov 2012|
|1y target est||N/A|
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Vaxart, Inc. (NASDAQ: VXRT) on behalf of long-term stockholders. Our investigation concerns whether the board of directors of Vaxart have breached their fiduciary duties to the company.
Glancy Prongay & Murray LLP ("GPM") announces its investigation of Vaxart, Inc. (NASDAQ: VXRT) concerning the Company and its directors’ and officers’ possible violations of state laws.
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Vaxart, Inc. ("Vaxart " or the "Company") (NASDAQ: VXRT) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Vaxart securities between June 25, 2020 and July 25, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/vxrt.